Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alice Boissard

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
International Journal of Oncology|May 30, 2020
Biomarkers of tumor invasiveness in proteomics (Review)Daniel L Pouliquen, Alice Boissard, Olivier Coqueret, et al.
Proteomics|October 12, 2013
Two-step OFFGEL approach for effective peptide separation compatible with iTRAQ labelingAlexis Rideau, Damien Besson, Alice Boissard, et al.
International Journal of Molecular Sciences|November 26, 2022
Proteomes of Residual Tumors in Curcumin-Treated Rats Reveal Changes in Microenvironment/Malignant Cell Crosstalk in a Highly Invasive Model of MesotheliomaDaniel L Pouliquen, Marine Malloci, Alice Boissard, et al.
Frontiers in Pharmacology|July 25, 2022
Curcuminoids as Modulators of EMT in Invasive Cancers: A Review of Molecular Targets With the Contribution of Malignant Mesothelioma StudiesDaniel L Pouliquen, Alice Boissard, Cécile Henry, et al.
International Journal of Molecular Sciences|August 27, 2021
Lymphoid Organ Proteomes Identify Therapeutic Efficacy Biomarkers Following the Intracavitary Administration of Curcumin in a Highly Invasive Rat Model of Peritoneal MesotheliomaDaniel L Pouliquen, Alice Boissard, Cécile Henry, et al.
International Journal of Oncology|December 16, 2021
Anterior gradient protein 2 is a marker of tumor aggressiveness in breast cancer and favors chemotherapy‑induced senescence escapeAmine Maarouf, Alice Boissard, Cécile Henry, et al.
Proteomics|April 6, 2019
iTRAQ-Based Quantitative Proteomic Analysis Strengthens Transcriptomic Subtyping of Triple-Negative Breast Cancer TumorsPascal Jézéquel, Catherine Guette, Hamza Lasla, et al.
Cancers|November 19, 2020
Curcumin Treatment Identifies Therapeutic Targets within Biomarkers of Liver Colonization by Highly Invasive Mesothelioma Cells-Potential Links with SarcomasDaniel L Pouliquen, Alice Boissard, Cécile Henry, et al.
Proteomics|April 11, 2019
Proteomics Approaches to Define Senescence Heterogeneity and Chemotherapy ResponseCoralie Petit, Jordan Guillon, Bertrand Toutain, et al.
Proteomics|July 19, 2019
OLFM4 Expression in Ductal Carcinoma In Situ and in Invasive Breast Cancer Cohorts by a SWATH-Based Proteomic ApproachIsabelle Valo, Pedro Raro, Alice Boissard, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
International Journal of Oncology|May 30, 2020
Biomarkers of tumor invasiveness in proteomics (Review)Daniel L Pouliquen, Alice Boissard, Olivier Coqueret, et al.
Proteomics|October 12, 2013
Two-step OFFGEL approach for effective peptide separation compatible with iTRAQ labelingAlexis Rideau, Damien Besson, Alice Boissard, et al.
International Journal of Molecular Sciences|November 26, 2022
Proteomes of Residual Tumors in Curcumin-Treated Rats Reveal Changes in Microenvironment/Malignant Cell Crosstalk in a Highly Invasive Model of MesotheliomaDaniel L Pouliquen, Marine Malloci, Alice Boissard, et al.
Frontiers in Pharmacology|July 25, 2022
Curcuminoids as Modulators of EMT in Invasive Cancers: A Review of Molecular Targets With the Contribution of Malignant Mesothelioma StudiesDaniel L Pouliquen, Alice Boissard, Cécile Henry, et al.
International Journal of Molecular Sciences|August 27, 2021
Lymphoid Organ Proteomes Identify Therapeutic Efficacy Biomarkers Following the Intracavitary Administration of Curcumin in a Highly Invasive Rat Model of Peritoneal MesotheliomaDaniel L Pouliquen, Alice Boissard, Cécile Henry, et al.
International Journal of Oncology|December 16, 2021
Anterior gradient protein 2 is a marker of tumor aggressiveness in breast cancer and favors chemotherapy‑induced senescence escapeAmine Maarouf, Alice Boissard, Cécile Henry, et al.
Proteomics|April 6, 2019
iTRAQ-Based Quantitative Proteomic Analysis Strengthens Transcriptomic Subtyping of Triple-Negative Breast Cancer TumorsPascal Jézéquel, Catherine Guette, Hamza Lasla, et al.
Cancers|November 19, 2020
Curcumin Treatment Identifies Therapeutic Targets within Biomarkers of Liver Colonization by Highly Invasive Mesothelioma Cells-Potential Links with SarcomasDaniel L Pouliquen, Alice Boissard, Cécile Henry, et al.
Proteomics|April 11, 2019
Proteomics Approaches to Define Senescence Heterogeneity and Chemotherapy ResponseCoralie Petit, Jordan Guillon, Bertrand Toutain, et al.
Proteomics|July 19, 2019
OLFM4 Expression in Ductal Carcinoma In Situ and in Invasive Breast Cancer Cohorts by a SWATH-Based Proteomic ApproachIsabelle Valo, Pedro Raro, Alice Boissard, et al.
Pageof 3